Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the addition of Rob 803 to methotrexate for rheumatoid arthritis has completed. Sponsor: OxyPharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Rob 803

Snippet

Sponsor: OxyPharma | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED